litlas
Log inCreate account

Joachim Listing

Active 1985–2024

84
Papers
24,386
Citations
77
h-index
84
i10-index

Citations

Citations per year for Joachim Listing1986: 2 citations1987: 3 citations1988: 1 citations1989: 2 citations1990: 3 citations1991: 1 citations1992: 1 citations1993: 2 citations1995: 1 citations1996: 1 citations1997: 9 citations1998: 4 citations1999: 6 citations2000: 3 citations2001: 5 citations2002: 24 citations2003: 47 citations2004: 67 citations2005: 146 citations2006: 120 citations2007: 148 citations2008: 145 citations2009: 171 citations2010: 188 citations2011: 319 citations2012: 220 citations2013: 260 citations2014: 237 citations2015: 248 citations2016: 178 citations2017: 216 citations2018: 166 citations2019: 695 citations2020: 691 citations2021: 521 citations2022: 364 citations2023: 263 citations2024: 412 citations2025: 109 citations2026: 6 citations1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,193 citing papers, 15.4% of this breakdownGermany: 715 citing papers, 9.2% of this breakdownUnited Kingdom: 660 citing papers, 8.5% of this breakdownNetherlands: 509 citing papers, 6.5% of this breakdownFrance: 434 citing papers, 5.6% of this breakdownCanada: 388 citing papers, 5% of this breakdownItaly: 379 citing papers, 4.9% of this breakdownSpain: 304 citing papers, 3.9% of this breakdownChina: 256 citing papers, 3.3% of this breakdownBelgium: 228 citing papers, 2.9% of this breakdownSwitzerland: 228 citing papers, 2.9% of this breakdownDenmark: 191 citing papers, 2.5% of this breakdown
0%15.4%Other 29.4%

Institutions

Fields

  • Medicine88.1%
  • Biochemistry, Genetics and Molecular Biology5.2%
  • Immunology and Microbiology4.1%
  • Nursing0.5%
  • Health Professions0.4%
  • Neuroscience0.3%
  • Other1.4%

Topics

  • Rheumatoid Arthritis Research and Therapies19.9%
  • Spondyloarthritis Studies and Treatments18.7%
  • Autoimmune and Inflammatory Disorders Research6.9%
  • Psoriasis: Treatment and Pathogenesis4.6%
  • Spine and Intervertebral Disc Pathology4%
  • Systemic Lupus Erythematosus Research3.4%
  • Other42.5%

Coauthors

All papers

Open in search
  1. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

    Authors: Martín Rudwaleit, Désirée van der Heijde, R. B. M. Landewé, Joachim Listing, Nurullah Akkoç, J. Brandt, Jürgen Braun, Chung‐Tei Chou, Eduardo Collantes‐Estévez, Maxime Dougados, Feng Huang, Jieruo Gu, Muhammad Asim Khan, Yeşim Kirazlı, Walter P. Maksymowych, Herman Mielants, Inge Juul Sørensen, S Ozgocmen, Euthalia Roussou, Raphael Valle-Oñate, Ulrich Weber, James Cheng‐Chung Wei, Joachim Sieper - Annals of the Rheumatic Diseases 2009 cited by 3,622

  2. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    Authors: David T. Felson, Josef S Smolen, George A. Wells, Bin Zhang, L. van Tuyl, Julia Funovits, Daniel Aletaha, Cornelia F Allaart, Joan M. Bathon, Stefano Bombardieri, Peter Brooks, Andrew Brown, Marco Matucci‐Cerinic, Hyon K. Choi, Bernard Combe, Maarten de Wit, Maxime Dougados, Paul Emery, Daniel E. Furst, Juan J. Gómez‐Reino, Gillian Hawker, Edward Keystone, Dinesh Khanna, John Kirwan, Tore K Kvien, Robert Landewé, Joachim Listing, Kaleb Michaud, E. Martín‐Mola, Pamela Montie, Theodore Pincus, Pamela Richards, Jeffrey N. Siegel, Lee S. Simon, Tuulikki Sokka, Vibeke Strand, Peter Tugwell, Alan Tyndall, Desirée van der Heijde, Suzanne Verstappen, Barbara White, Frederick Wolfe, A. Zink, Maarten Boers - Annals of the Rheumatic Diseases 2011 cited by 1,019

  3. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    Authors: Martín Rudwaleit, R. Landewé, Désirée van der Heijde, Joachim Listing, J. Brandt, Joseph M. Braun, R Burgos-Vargas, Eduardo Collantes‐Estévez, John C. Davis, Ben A. C. Dijkmans, Maxime Dougados, Paul Emery, Irene E. van der Horst‐Bruinsma, Robert D. Inman, Muhammad Asim Khan, Marjatta Leirisalo‐Repo, S. van der Linden, Walter P. Maksymowych, Herman Mielants, Ignazio Olivieri, R D Sturrock, Kurt De Vlam, Joachim Sieper - Annals of the Rheumatic Diseases 2009 cited by 943

  4. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

    Authors: Désirée van der Heijde, E. Lie, Tore K Kvien, Joachim Sieper, Filip Van den Bosch, Joachim Listing, Joseph M. Braun, R. Landewé - Annals of the Rheumatic Diseases 2008 cited by 631

  5. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

    Authors: Cindy Strehl, J. W. J. Bijlsma, Maarten de Wit, Maarten Boers, N. Caeyers, Maurizio Cutolo, Bhaskar Dasgupta, William G Dixon, Rinie Geenen, T. Huizinga, Alison Kent, Annette de Thurah, Joachim Listing, Xavier Mariette, David Ray, Hans Ulrich Scherer, Raphaèle Séror, Cornelia M Spies, Simon Tarp, Dieter Wiek, Kevin Winthrop, Frank Buttgereit - Annals of the Rheumatic Diseases 2016 cited by 331

  6. The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort

    Authors: Martín Rudwaleit, Hildrun Haibel, Xenofon Baraliakos, Joachim Listing, E. Märker‐Hermann, H. Zeidler, Jürgen Braun, Joachim Sieper - Arthritis & Rheumatism 2009 cited by 725

  7. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

    Authors: Joachim Listing, Kerstin Gerhold, A. Zink - Lara D. Veeken 2012 cited by 542

  8. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

    Authors: Joachim Listing, Jörn Kekow, Bernhard Manger, Gerd‐Rüdiger Burmester, Dagmar Pattloch, A. Zink, Anja Strangfeld - Annals of the Rheumatic Diseases 2013 cited by 288

  9. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

    Authors: Jürgen Braun, J. Brandt, Joachim Listing, A. Zink, Rieke Alten, W. Golder, E Gromnica-lhle, H. Kellner, Andreas Krause, Matthias Schneider, H. Sörensen, H. Zeidler, Wolfgang Thriene, Joachim Sieper - The Lancet 2002 cited by 1,266

  10. Baseline radiographic damage, elevated acute‐phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis

    Authors: Denis Poddubnyy, Hildrun Haibel, Joachim Listing, E. Märker‐Hermann, H. Zeidler, Jürgen Braun, Joachim Sieper, Martín Rudwaleit - Arthritis & Rheumatism 2011 cited by 468

  11. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial

    Authors: Claudia Kedor, Joachim Listing, Jan Zernicke, Anja Weiß, Frank Behrens, Norbert Blank, Jörg Henes, Joern Kekow, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Eva Seipelt, Christof Specker, Eugen Feist - Annals of the Rheumatic Diseases 2020 cited by 99

  12. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

    Authors: Anja Strangfeld, Maria Eveslage, Matthias Schneider, H. J. Bergerhausen, T. Klopsch, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2011 cited by 362

  13. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)

    Authors: Joachim Sieper, Joachim Listing, Denis Poddubnyy, In‐Ho Song, Kay‐Geert Hermann, Johanna Callhoff, Uta Syrbe, Jürgen Braun, Martín Rudwaleit - Annals of the Rheumatic Diseases 2015 cited by 227

  14. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

    Authors: Anja Strangfeld, Franka Hierse, Rolf Rau, Gerd‐Ruediger Burmester, Brigitte Krummel-Lorenz, W. Demary, Joachim Listing, A. Zink - Arthritis Research & Therapy 2010 cited by 262

  15. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs

    Authors: Anja Strangfeld, Adrian Richter, Britta Siegmund, P. Herzer, Karin Rockwitz, W. Demary, Martin Aringer, Yvette Meißner, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2016 cited by 193

  16. Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria

    Authors: Martín Rudwaleit, Anke Metter, Joachim Listing, Joachim Sieper, Jürgen Braun - Arthritis & Rheumatism 2006 cited by 545

  17. Infections in patients with rheumatoid arthritis treated with biologic agents

    Authors: Joachim Listing, Anja Strangfeld, S. Kary, Rolf Rau, U von Hinueber, Maria Stoyanova‐Scholz, Erika Gromnica‐Ihle, Christian Antoni, P. Herzer, Jörn Kekow, Matthias Schneider, A. Zink - Arthritis & Rheumatism 2005 cited by 687

  18. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis

    Authors: Denis Poddubnyy, M. Rudwaleit, Hildrun Haibel, Joachim Listing, Elisabeth Märker‐Hermann, H. Zeidler, J. Braun, J. Sieper - Annals of the Rheumatic Diseases 2011 cited by 352

  19. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

    Authors: Louise Mercer, Johan Askling, Pauline Raaschou, William G Dixon, Lene Dreyer, Merete Lund Hetland, Anja Strangfeld, A. Zink, Xavier Mariette, Axel Finckh, Helena Canhão, Florenzo Iannone, Jakub Závada, Jacques Morel, Jacques‐Eric Gottenberg, Kimme L Hyrich, Joachim Listing - Annals of the Rheumatic Diseases 2016 cited by 188

  20. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanercept

    Authors: Jürgen Braun, Xenofon Baraliakos, Joachim Listing, Joachim Sieper - Arthritis & Rheumatism 2005 cited by 442

  21. Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

    Authors: Xenofon Baraliakos, Joachim Listing, Martín Rudwaleit, Hildrun Haibel, J. Brandt, Joachim Sieper, Jürgen Braun - Annals of the Rheumatic Diseases 2007 cited by 268

  22. Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis

    Authors: Johanna Callhoff, Joachim Sieper, Anja Weiß, A. Zink, Joachim Listing - Annals of the Rheumatic Diseases 2014 cited by 213

  23. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

    Authors: Xenofon Baraliakos, F. Heldmann, Johanna Callhoff, Joachim Listing, Thierry Appelboom, J. Brandt, Filip Van den Bosch, Maxime Bréban, GR Burmester, Maxime Dougados, Paul Emery, Hill Gaston, Mathias Grünke, Irene E. van der Horst‐Bruinsma, Robert Landewé, Marjatta Leirisalo‐Repo, Joachim Sieper, Kurt de Vlam, Dimitrios A. Pappas, Uta Kiltz, Désirée van der Heijde, Jürgen Braun - Annals of the Rheumatic Diseases 2013 cited by 195

  24. Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

    Authors: Joachim Listing, Anja Strangfeld, Jörn Kekow, Matthias Schneider, A Kapelle, Siegfried Wassenberg, A. Zink - Arthritis & Rheumatism 2008 cited by 195